Ménière's disease.
D001621:Betahistine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004791:Enzyme Inhibitors; D006801:Humans; D008575:Meniere Disease / Q000188:drug therapy*; D009325:Nausea / Q000188:drug therapy; D010919:Placebos; D014012:Tinnitus / Q000188:drug therapy; D014717:Vertigo / Q000188:drug therapy
D004791:Enzyme Inhibitors; D010919:Placebos; D001621:Betahistine